Journal article 858 views 141 downloads
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Lawrence A. Leiter,
Stephen C. Bain,
Irene Hramiak,
Esteban Jódar,
Sten Madsbad,
Theis Gondolf,
Thomas Hansen,
Ingrid Holst,
Ildiko Lingvay,
Steve Bain 
Cardiovascular Diabetology, Volume: 18, Issue: 1
Swansea University Author:
Steve Bain
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY).
Download (1.21MB)
DOI (Published version): 10.1186/s12933-019-0871-8
Abstract
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
| Published in: | Cardiovascular Diabetology |
|---|---|
| ISSN: | 1475-2840 |
| Published: |
2019
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa50453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| first_indexed |
2019-05-20T11:26:45Z |
|---|---|
| last_indexed |
2019-06-19T20:51:27Z |
| id |
cronfa50453 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2019-06-19T10:09:22.3350512</datestamp><bib-version>v2</bib-version><id>50453</id><entry>2019-05-20</entry><title>Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-05-20</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Cardiovascular Diabetology</journal><volume>18</volume><journalNumber>1</journalNumber><publisher/><issnElectronic>1475-2840</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-12-31</publishedDate><doi>10.1186/s12933-019-0871-8</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2019-06-19T10:09:22.3350512</lastEdited><Created>2019-05-20T09:44:36.6097731</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Lawrence A.</firstname><surname>Leiter</surname><order>1</order></author><author><firstname>Stephen C.</firstname><surname>Bain</surname><order>2</order></author><author><firstname>Irene</firstname><surname>Hramiak</surname><order>3</order></author><author><firstname>Esteban</firstname><surname>Jódar</surname><order>4</order></author><author><firstname>Sten</firstname><surname>Madsbad</surname><order>5</order></author><author><firstname>Theis</firstname><surname>Gondolf</surname><order>6</order></author><author><firstname>Thomas</firstname><surname>Hansen</surname><order>7</order></author><author><firstname>Ingrid</firstname><surname>Holst</surname><order>8</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>9</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>10</order></author></authors><documents><document><filename>0050453-19062019100837.pdf</filename><originalFilename>50453.pdf</originalFilename><uploaded>2019-06-19T10:08:37.4070000</uploaded><type>Output</type><contentLength>1316139</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-06-18T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
| spelling |
2019-06-19T10:09:22.3350512 v2 50453 2019-05-20 Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-05-20 BMS Journal Article Cardiovascular Diabetology 18 1 1475-2840 31 12 2019 2019-12-31 10.1186/s12933-019-0871-8 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2019-06-19T10:09:22.3350512 2019-05-20T09:44:36.6097731 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Lawrence A. Leiter 1 Stephen C. Bain 2 Irene Hramiak 3 Esteban Jódar 4 Sten Madsbad 5 Theis Gondolf 6 Thomas Hansen 7 Ingrid Holst 8 Ildiko Lingvay 9 Steve Bain 0000-0001-8519-4964 10 0050453-19062019100837.pdf 50453.pdf 2019-06-19T10:08:37.4070000 Output 1316139 application/pdf Version of Record true 2019-06-18T00:00:00.0000000 Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY). true eng |
| title |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| spellingShingle |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial Steve Bain |
| title_short |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| title_full |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| title_fullStr |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| title_full_unstemmed |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| title_sort |
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
| author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
| author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
| author |
Steve Bain |
| author2 |
Lawrence A. Leiter Stephen C. Bain Irene Hramiak Esteban Jódar Sten Madsbad Theis Gondolf Thomas Hansen Ingrid Holst Ildiko Lingvay Steve Bain |
| format |
Journal article |
| container_title |
Cardiovascular Diabetology |
| container_volume |
18 |
| container_issue |
1 |
| publishDate |
2019 |
| institution |
Swansea University |
| issn |
1475-2840 |
| doi_str_mv |
10.1186/s12933-019-0871-8 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2019-12-31T04:01:55Z |
| _version_ |
1763753187468115968 |
| score |
11.037581 |